Steven D. Targum
Hoofd Techniek/Wetenschap/O&O bij Functional Neuromodulation Ltd.
Profiel
Steven D.
Targum is the founder of PharmaStar LLC.
He is currently the Chief Medical Officer at Functional Neuromodulation Ltd.
His former positions include Vice Chairman-Mental Health Sciences Department at Hahnemann University, Executive-in-Residence at Oxford Bioscience Partners, Chief Medical Officer at BrainCells, Inc. and MSI Methylation Sciences, Inc., and Consultant at The General Hospital Corp.
He received his undergraduate degree from Colgate University and his doctorate from Icahn School of Medicine at Mount Sinai.
Actieve functies van Steven D. Targum
| Bedrijven | Functie | Begin |
|---|---|---|
Functional Neuromodulation Ltd.
 Functional Neuromodulation Ltd. Medical SpecialtiesHealth Technology Functional Neuromodulation Ltd. operates as a holding company which engages in the design and development of deep brain stimulation therapies for memory and cognitive disorders. It uses a surgically implanted medical device, similar to a pacemaker, to deliver mild electrical pulses to targeted areas of the brain. The company was founded by Andres Lozano in 2010 and is headquartered in Boston, MA. | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Steven D. Targum
| Bedrijven | Functie | Einde |
|---|---|---|
| Hahnemann University | Corporate Officer/Principal | 01-01-1995 |
PharmaStar LLC
 PharmaStar LLC Miscellaneous Commercial ServicesCommercial Services Part of United BioSource Corp., PharmaStar LLC provides training services for medical researchers. The company is based in Wayne, PA. PharmaStar was acquired by United BioSource Corp. on April 21, 2005. The company was founded by Darren M. Black, Steven D. Targum, Brian Esterly. | Oprichter | - |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
MSI Methylation Sciences, Inc.
 MSI Methylation Sciences, Inc. Pharmaceuticals: MajorHealth Technology MSI Methylation Sciences, Inc. engages in drug development through compound leverage. It focuses on developing pharmaceuticals based on molecules with proven efficacy that are under exploited in pharmaceutical markets. The firm offers s-adenosyl methionine, is a prescription drug used as a dietary supplement. The company was founded by Barry J. Guld and Nancy Harrison in 2006 and is headquartered in Burnaby, Canada. | Hoofd Techniek/Wetenschap/O&O | - |
Oxford Bioscience Partners
 Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston. | Private Equity Investor | - |
Opleiding van Steven D. Targum
| Colgate University | Undergraduate Degree |
| Icahn School of Medicine at Mount Sinai | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
BrainCells, Inc.
 BrainCells, Inc. Pharmaceuticals: MajorHealth Technology BrainCells Inc. discovers and develops drugs. The company was founded by Fred H. Gage and Harry F. Hixson, Jr. in 2003 and is headquartered in San Diego, CA. | Health Technology |
Oxford Bioscience Partners
Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston. | Finance |
MSI Methylation Sciences, Inc.
MSI Methylation Sciences, Inc. Pharmaceuticals: MajorHealth Technology MSI Methylation Sciences, Inc. engages in drug development through compound leverage. It focuses on developing pharmaceuticals based on molecules with proven efficacy that are under exploited in pharmaceutical markets. The firm offers s-adenosyl methionine, is a prescription drug used as a dietary supplement. The company was founded by Barry J. Guld and Nancy Harrison in 2006 and is headquartered in Burnaby, Canada. | Health Technology |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Health Services |
PharmaStar LLC
PharmaStar LLC Miscellaneous Commercial ServicesCommercial Services Part of United BioSource Corp., PharmaStar LLC provides training services for medical researchers. The company is based in Wayne, PA. PharmaStar was acquired by United BioSource Corp. on April 21, 2005. The company was founded by Darren M. Black, Steven D. Targum, Brian Esterly. | Commercial Services |
Functional Neuromodulation Ltd.
Functional Neuromodulation Ltd. Medical SpecialtiesHealth Technology Functional Neuromodulation Ltd. operates as a holding company which engages in the design and development of deep brain stimulation therapies for memory and cognitive disorders. It uses a surgically implanted medical device, similar to a pacemaker, to deliver mild electrical pulses to targeted areas of the brain. The company was founded by Andres Lozano in 2010 and is headquartered in Boston, MA. | Health Technology |
